An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
Top Cited Papers
Open Access
- 11 July 2004
- journal article
- technical report
- Published by Springer Nature in Nature Medicine
- Vol. 10 (8) , 871-875
- https://doi.org/10.1038/nm1080
Abstract
Passive serotherapy can confer immediate protection against microbial infection, but methods to rapidly generate human neutralizing monoclonal antibodies are not yet available. We have developed an improved method for Epstein-Barr virus transformation of human B cells. We used this method to analyze the memory repertoire of a patient who recovered from severe acute respiratory syndrome coronavirus (SARS-CoV) infection and to isolate monoclonal antibodies specific for different viral proteins, including 35 antibodies with in vitro neutralizing activity ranging from 10−8M to 10−11M. One such antibody confers protection in vivo in a mouse model of SARS-CoV infection. These results show that it is possible to interrogate the memory repertoire of immune donors to rapidly and efficiently isolate neutralizing antibodies that have been selected in the course of natural infection.Keywords
This publication has 31 references indexed in Scilit:
- An Alphavirus Replicon Particle Chimera Derived from Venezuelan Equine Encephalitis and Sindbis Viruses Is a Potent Gene-Based Vaccine Delivery VectorJournal of Virology, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Maintenance of Serological Memory by Polyclonal Activation of Human Memory B CellsScience, 2002
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986
- Antigen-specific interaction between T and B cellsNature, 1985
- Human Anti-Tetanus Toxoid Monoclonal Antibody Secreted by EBV-Transformed Human B Cells Fused with Murine MyelomaHybridoma, 1982
- EB virus-induced B lymphocyte cell lines producing specific antibodyNature, 1977
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- Beitrag zur kollektiven Behandlung pharmakologischer ReihenversucheNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1931